Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis

Thumbnail Image

Date

2014

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Background: RA is a chronic systemic inflammatory disorder with a prevalence of up to 1%. In the absence of adequate treatment, progressive joint deformity and loss of function occurs with associated premature cardiovascular morbidity. Tocilizumab (TCZ) [1], a humanized anti IL-6 receptor (anti IL-6R) antibody, has been shown in several large randomized controlled trials to be efficacious and well tolerated in the treatment of RA.

Description

Keywords

Citation

URI

https://dspace-test.anu.edu.au/handle/1885/733738220

Collections

DevOps Pure Testing

Source

Rheumatology

Type

Article

Book Title

Entity type

Access Statement

License Rights

DOI

10.1093/rheumatology/keu168

Restricted until

DSpace software copyright © 2002-2026 LYRASIS